GSC
EW icon

Ground Swell Capital’s Edwards Lifesciences EW Stock Holding History

Ground Swell Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$28K Buy
1,662
+942
+131% +$14.9K 0.05% 390
2014
Q2 		$10K Buy
+720
New +$9.76K 0.02% 709

Other funds holding EW

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ground Swell Capital's EW Position: Q3 2014 in Review

Ground Swell Capital increased its Edwards Lifesciences (EW) stake by 131% in Q3 2014, buying an estimated $14.9K and bringing the position to 1,662 shares worth $28K. The position accounts for 0.05% of the portfolio, ranked #390.

Ground Swell Capital first reported a position in EW in Q2 2014 and has held it in 2 quarters since. 496 funds tracked by Wall St. Rank hold EW as of Q3 2014.

  • Ground Swell Capital held 1,662 shares of Edwards Lifesciences worth $28K as of Q3 2014.
  • Ground Swell Capital bought 942 Edwards Lifesciences shares in Q3 2014, an estimated $14.9K.
  • Edwards Lifesciences made up 0.05% of Ground Swell Capital's portfolio in Q3 2014, its #390 holding.
  • Ground Swell Capital first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 2 quarters since.
  • 496 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.